AzTrials
AzTrials

Physical ActivityactivityNCT07137520

The Impact of Various Exercise Intensities on Energy Expenditure Metabolism

An observational study of Physical Activity, run by Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences at 1 site in China.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this observational study is to learn about the effects of physical activity in adult on metabolic response. The main question it aims to answer is: if physical activity is unlimited to increase the total energy expenditure (TEE)? Participants will engage in the following measurements: Record their daily… Read more about this study

Who is it for?
Ages 18 to 60 yearsHealthy volunteers can take part
Conditions the study is for
Physical Activity
What is being tested?
Observation without intervention
How many people
100 participants
Where
1 siteChina
Study dates
1 Sep 2025to Dec 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Study population: Residents of Shenzhen, Guangzhou, China

Who may be able to join

  • BMI ≥ 18.5 kg/m2

Who cannot join

  • Individuals who have undergone major surgery in the past 6 months (excluding tooth extraction);
  • Individuals with severe metabolic and cardiovascular diseases such as diabetes, hypoglycemia, and hypertension;
  • Individuals with exercise-related injuries, including joint diseases and fractures;
  • Individuals diagnosed with infectious diseases such as HIV, tuberculosis, malaria, etc.;
  • Individuals with mental and neurological disorders including anorexia nervosa;
  • Individuals who have attempted weight loss or gain through various methods in the past three months;
  • Individuals in preconception, pregnancy, and lactation periods;
  • Individuals with autism and those with metal implants in their bodies.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

John R Speakman, PhD contact

+8615810868669

j.speakman@abdn.ac.uk

Xinyi BI, PhD contact

+8614774821721

xy.bi@siat.ac.cn

China1 site
  • Shenzhen Institutes of Advanced Technology,Chinese Academy of Sciences

    Shenzhen, Guangdong

    John R Speakman, 15810868669, j.speakman@abdn.ac.uk

Other trials in China

About this study

Official title: An Observational Study on the Relationship Between Different Exercise Intensities and Energy Expenditure Metabolism

The goal of this observational study is to learn about the effects of physical activity in adult on metabolic response. The main question it aims to answer is:

  • if physical activity is unlimited to increase the total energy expenditure (TEE)?

Participants will engage in the following measurements:

  • Record their daily physical activity by GT3X.
  • Measure TEE by doubly-labeled water (DLW) method
  • Measure basal energy expenditure(BEE) and thermic effect of food(TEF) by respiratory chamber
Read the detailed description

The purpose of this study is to explore the effect of various physical activities on metabolic and behavior response. Energy expenditure, body composition, and metabolism will be measured by the following measurements:

  • TEE:

TEE will be measured using the DLW method. Urine samples from all participants in the DLW subset will be stored at -20℃ and shipped on dry ice for analysis in the laboratory of Prof. John Speakman at the Shenzhen Institutes of Advanced Technology, Chinese academy of sciences. Isotopes will be measured in benchtop near-infrared isotope gas analyzer, and mean CO2 production will be calculated from isotope ratios using the recently derived equation. TEE will then be calculated using mean CO2 production.

  • REE and TEF:

REE and TEF will be measured by indirect calorimetry while participants are resting supine in a respiratory chamber with thermoneutral conditions. Oxygen consumption and CO2 production will be measured to calculate energy expenditure. REE will be consistently measured throughout sleeping at night and in the morning after overnight fasting, and TEF will be measured after breakfast.

  • Physical activity:

Physical activity of the participants will be recorded using GT3X accelerometer worn near the hip for a consecutive period of 14 days. The monitor should not be worn while bathing or swimming. The first day is discarded along with any day with less than 12 hours of wear. For a valid measure the goal is to get 2 weekday and 2 weekend days.

  • VO2max test:

Participants need to warm up with simple stretching or light aerobic exercise before the test. The test will be conducted on a treadmill. A comfortable running speed acceptable to the participants will be set. The treadmill's incline will be increased by 10% every two minutes until the individual reaches their physical limit and can no longer continue. During this test, a respiratory mask and gas analyzer will be used to measure the concentration of oxygen (O2) and carbon dioxide (CO2) in the breath to calculate VO2max.

  • Food intake

Photographic and food weighing methods to record food intake for two random days throughout the period of DLW measurement.

  • Blood glucose

Fasting and post-prandial glucose will be recorded by a continuous glucose monitoring system.

  • Body composition:

Fat mass will be measured by Magnetic Resonance Imaging (MRI, Shanghai united imaging, uMR 790 ).

Bioimpedance Analysis will measure fat-free mass (Tanita, MC-980). Bone mass will be measured by Dual Energy X-ray Absorptiometry (DXA, Horizon Wi, HOLOGIC).

  • Body weight:

At visit 1, fasting body weight will be measured using a calibrated seca at the beginning of the visit. Fasting weight will be measured at visit 2 and, if applicable.

  • Height:

Height (to +0.1 cm) will be measured by seca 217 stable without wearing shoes.

  • Waist circumference:

Hip and waist circumference (to +0.3 cm) will be measured using a whole body laser scanner.

  • Blood pressure:

Systolic and diastolic blood pressure will be measured using an Omron digital sphygmomanometer.

Being tested
Observation without intervention
Keywords
Metabolic response, Energy expenditure, Physical fitness
Medical subject headings
Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Observation without interventionOther

    Observation without intervention

Study groups in NCT07137520
Study groupRoleWhat they receive
Sedentary groupGodin scale score ≥ 24
Receives: Other: Observation without intervention
Moderately active group14≥ Godin scale score ≥ 23
Receives: Other: Observation without intervention
Active groupGodin scale score <14
Receives: Other: Observation without intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Differences in total energy expenditure (TEE) measured by the doubly labeled water (DLW) method across experimental groups

    • The change in TEE will be evaluated using the DLW. Urine samples from all participants in the DLW subset will be stored at -20℃ and shipped on dry ice for analysis in the laboratory of Dr. John Speakman at the University of Aberdeen, or the Shenzhen Institutes of Advanced Technology, Chinese academy of sciences. Isotopes will be measured in benchtop near-infrared isotope gas analyzer, and mean CO2 production will be calculated from isotope ratios using the recently derived equation (Speakman et al 2021: Cell reports medicine). TEE will then be calculated using mean CO2 production using the Weir equation.

    Measured: 14days

  2. Differences in non-exercise physical activity across experimental groups

    • Physical activity of the participants will be recorded using GT3X accelerometer worn near the hip for a consecutive period of 14 days.

    Measured: 14days

  3. Differences in resting energy expenditure (REE) measured by respiratory chamber across experimental groups

    • REE will be evaluated by respiratory chamber.

    Measured: 1 day

  4. Differences in thermic effect of food (TEF) measured by respiratory chamber across experimental groups

    • TEF will be evaluated by respiratory chamber.

    Measured: 1 day

  5. Differences in exercise energy expenditure (EEE) measured by COSMED across experimental groups

    • EEE will be evaluated using an indirect calorimetry COSMED.

    Measured: 1 hour

  6. Differences in food intake across experimental groups

    Photographic and food weighing methods to record food intake for two random days throughout the period of DLW measurement

    Measured: 2 days

Secondary outcomes (7)
  1. Differences in sedentary time measured by GT3X accelerometer across experimental groups

    • Sedentary time will be represented from the GT3X accelerometer.

    Measured: 14 days

  2. Differences in glucose across experimental groups

    Fasting and post-prandial glucose will be recorded by a continuous glucose monitoring system.

    Measured: 7 days

  3. Differences in fat mass across experimental groups

    Fat mass will be measured by Magnetic Resonance Imaging (Shanghai united imaging, uMR 790 ).

    Measured: 10 minutes

  4. Differences in fat-free mass across experimental groups

    Fat-free mass will be measured by Bioimpedance Analysis (Tanita, MC-980).

    Measured: 2 minutes

  5. Differences in bone mass intensity across experimental groups

    Bone mass intensity will be measured by DXA( Horizon Wi, HOLOGIC)

    Measured: 7 minutes

  6. Differences in circulating hormones across experimental groups

    The nurse will collect the fasting blood sample. Metabolomics will analyze circulating hormones and metabolites.

    Measured: 1 minutes for collection, 7 days for analysis.

  7. Differences in intestinal microbiota across experimental groups

    Feces will be collected for gut microbiome analysis of intestinal microbiota.

    Measured: 5 minutes for collection, 7 days for analysis.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Aug 2025
  2. Study start1 Sep 2025 (estimated)
  3. Primary completionDec 2026 (estimated)
  4. Study completionDec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07137520
Sponsor's protocol ID
SIAT-IRB-240615-H0893
Other IDs
SIATCAS
Acronym
activity
Status last verified
Aug 2025
First submitted
3 Apr 2025
Last updated
22 Aug 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Speakman JR, Yamada Y, Sagayama H, Berman ESF, Ainslie PN, Andersen LF, Anderson LJ, Arab L, Baddou I, Bedu-Addo K, Blaak EE, Blanc S, Bonomi AG, Bouten CVC, Bovet P, Buchowski MS, Butte NF, Camps SGJA, Close GL, Cooper JA, Creasy SA, Das SK, Cooper R, Dugas LR, Ebbeling CB, Ekelund U, Entringer S, Forrester T, Fudge BW, Goris AH, Gurven M, Hambly C, El Hamdouchi A, Hoos MB, Hu S, Joonas N, Joosen AM, Katzmarzyk P, Kempen KP, Kimura M, Kraus WE, Kushner RF, Lambert EV, Leonard WR, Lessan N, Ludwig DS, Martin CK, Medin AC, Meijer EP, Morehen JC, Morton JP, Neuhouser ML, Nicklas TA, Ojiambo RM, Pietilainen KH, Pitsiladis YP, Plange-Rhule J, Plasqui G, Prentice RL, Rabinovich RA, Racette SB, Raichlen DA, Ravussin E, Reynolds RM, Roberts SB, Schuit AJ, Sjodin AM, Stice E, Urlacher SS, Valenti G, Van Etten LM, Van Mil EA, Wells JCK, Wilson G, Wood BM, Yanovski J, Yoshida T, Zhang X, Murphy-Alford AJ, Loechl CU, Melanson EL, Luke AH, Pontzer H, Rood J, Schoeller DA, Westerterp KR, Wong WW; IAEA DLW database group. A standard calculation methodology for human doubly labeled water studies. Cell Rep Med. 2021 Feb 16;2(2):100203. doi: 10.1016/j.xcrm.2021.100203. eCollection 2021 Feb 16.

    PubMed 33665639
  • Pontzer H, Durazo-Arvizu R, Dugas LR, Plange-Rhule J, Bovet P, Forrester TE, Lambert EV, Cooper RS, Schoeller DA, Luke A. Constrained Total Energy Expenditure and Metabolic Adaptation to Physical Activity in Adult Humans. Curr Biol. 2016 Feb 8;26(3):410-7. doi: 10.1016/j.cub.2015.12.046. Epub 2016 Jan 28.

    PubMed 26832439

Questions about this trial

What is this clinical trial studying?

An observational study of Physical Activity, run by Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 22 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact John R Speakman, PhD (+8615810868669, j.speakman@abdn.ac.uk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Differences in total energy expenditure (TEE) measured by the doubly labeled water (DLW) method across experimental groups (time frame: 14days). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07137520, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Aug 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in